Skip to content

Research

Research holds the key to the cure for type 1 diabetes. Funds raised by JDRF move life-altering research out of the lab and into human clinical trials.

JDRF funding and leadership is associated with most major scientific breakthroughs in type 1 research, such as islet transplantation. In fact, JDRF funds a major portion of all type 1 diabetes research worldwide, more than any other charity. JDRF provided $123 million to diabetes research in FY 2006, and is responsible for more than $1 billion in direct funding since it was founded.

JDRF is driven by results and successes in three major cure goals: restoring normal blood sugar, preventing and reversing diabetes-related complications, and preventing diabetes. Working toward these goals, JDRF has taken the lead in nurturing human clinical trials in such critical areas as the development of transplant tolerance and alternative sources of insulin-producing cells for transplant. Learn more about JDRF's targeted areas of research for the next five years.

Locally, JDRF has awarded research grants to The JDRF Center for Translational Research at the Benaroya Research Institute at Virginia Mason, the JDRF Center for Human Islet Transplantation at the Pacific Northwest Research Institute (PNRI), the JDRF Center for Translational Research at the Institute for Systems Biology, the University of Washington Medical Center, and Washington State University.

JDRF Research Efforts and Information

Research in the Northwest

JDRF's mission: Find a cure for diabetes and its complications through the support of research.